A-29, r. 5 - Regulation respecting the application of the Health Insurance Act

Section 60 Disposition versions

2021-01-25

60. The pharmaceutical services referred to below must be deemed insured services for the purposes of the third paragraph of section 3 of the Act:

(a)  filling and renewal of a prescription;

(b)  refusal to fill a prescription or to renew it;

(c)  pharmaceutical opinion (opinion with reasons of a pharmacist on the pharmaco-therapeutic history of an insured person prepared under his authority, or on the therapeutic value of on or all of the treatment ordered by prescription, given in writing to the prescriber);

(d)  transmission of a medication profile;

(e)  on-call service;

(f)  a service rendered in order to administer a medication orally, topically, subcutaneously, intradermally or intramuscularly, or by inhalation, to establish its appropriate usage, in accordance with the Regulation respecting the initiation and modification of medication therapy, the administration of a medication and the prescription of tests by a pharmacist (chapter P-10, r. 3.2);

(g)  a service rendered, in accordance with the Regulation respecting the initiation and modification of medication therapy, the administration of a medication and the prescription of tests by a pharmacist, in order:

i.  to extend a prescription so that a treatment prescribed to a patient is not interrupted, in accordance with subparagraph 6 of the second paragraph of section 17 of the Pharmacy Act (chapter P-10);

ii.  to adjust or terminate a medication therapy to ensure its effectiveness or a patient’s safety;

iii.  to replace a prescribed medication with another medication, in the cases provided in paragraphs a to d of subparagraph 8 of the second paragraph of section 17 of the Pharmacy Act;

(h)  a service rendered in order to prescribe laboratory analyses or other tests, for the purpose of ensuring the appropriate use of medications, in accordance with the Regulation respecting the initiation and modification of medication therapy, the administration of a medication and the prescription of tests by a pharmacist;

(i)  a service rendered following a hospitalization lasting more than 24 hours, targeting at least three medications prescribed for a period of 90 days or more that must be added to the therapy underway, be terminated or be adjusted with respect to their dose or dosage regimen and that are not calcium, vitamin B12 per os or vitamin D, acetaminophen, acetylsalicylic acid, contraceptives, laxative-purgatives or proton-pump inhibitors;

(j)  (paragraph replaced);

(k)  (paragraph replaced);

(k.1)  (paragraph replaced);

(l)  (paragraph replaced);

(m)  (paragraph replaced);

(n)  (paragraph replaced);

(o)  (paragraph replaced).

The services referred to in subparagraphs (a) and (b) of the first paragraph must relate to a medication on the list of medications drawn up by the Minister under section 60 of the Act respecting prescription drug insurance (chapter A-29.01).

The services referred to in subparagraphs (c) and (e) of the first paragraph must relate to at least one medication on the list of medications drawn up by the Minister under section 60 of the Act respecting prescription drug insurance.

R.R.Q., 1981, c. A-29, r. 1, s. 60; O.C. 1770-84, s. 1; O.C. 505-2015, s. 1; S.Q. 2020, c. 4, s. 12; O.C. 50-2021, s. 1.

2020-03-17

60. The pharmaceutical services referred to below must be deemed insured services for the purposes of the third paragraph of section 3 of the Act:

(a)  filling and renewal of a prescription;

(b)  refusal to fill a prescription or to renew it;

(c)  pharmaceutical opinion (opinion with reasons of a pharmacist on the pharmaco-therapeutic history of an insured person prepared under his authority, or on the therapeutic value of on or all of the treatment ordered by prescription, given in writing to the prescriber);

(d)  transmission of a medication profile;

(e)  on-call service;

(f)  extension of a physician’s prescription, so that the treatment prescribed by the physician to a patient shall not be interrupted, according to the terms and conditions referred to in subparagraph (6) of the second paragraph of section 17 of the Pharmacy Act (chapter P-10) as well as in the Regulation respecting the extension or adjustment of a physician’s prescription by a pharmacist and the substitution of a medication prescribed (chapter P-10, r. 19.1);

(g)  adjustment of a physician’s prescription, by modifying the dosage form, dose, quantity or dosage regimen of a prescribed medication, according to the terms and conditions determined by the Regulation respecting the extension or adjustment of a physician’s prescription by a pharmacist and the substitution of a medication prescribed;

(h)  replacement of a prescribed medication, where it is completely out of stock in Québec, with another medication of the same therapeutic sub-class, according to the terms and conditions determined by the Regulation respecting the extension or adjustment of a physician’s prescription by a pharmacist and the substitution of a medication prescribed;

(i)  administration of a medication orally, topically, subcutaneously, intradermally or intramuscularly, or by inhalation, in order to establish its appropriate usage or in an emergency situation, according to the terms and conditions determined by the Regulation respecting the administration of medication by pharmacists (chapter P-10, r. 3.1);

(j)  prescription of laboratory analyses for the purpose of the monitoring of a medicational therapy by a pharmacist practising in a community pharmacy, according to the terms and conditions determined by the Regulation respecting certain professional activities that may be engaged in by a pharmacist (chapter M-9, r. 12.2);

(k)  prescription of a medication when no diagnosis is required, in the cases and according to the terms and conditions determined by the Regulation respecting the prescription of a medication by a pharmacist (chapter P-10, r. 18.2), except for the case referred to in item 6 or 12 of Schedule I to that regulation;

(k.1)  prescription of an over-the-counter medication determined in a regulation made under section 37.1 of the Pharmacy Act, if the person’s clinical situation or any other circumstance so warrants;

(l)  prescription of a medication for a minor condition, according to the terms and conditions determined by the Regulation respecting certain professional activities that may be engaged in by a pharmacist;

(m)  taking charge of the adjustment of a dose of a medication to attain a therapeutic target, according to the terms and conditions determined by the Regulation respecting the extension or adjustment of a physician’s prescription by a pharmacist and the substitution of a medication prescribed. The cost of tests performed in a pharmacy are not included in the pharmacist’s remuneration for this service;

(n)  evaluation of the need for the prescription of a medication when no diagnosis is required, in the cases and according to the terms and conditions determined by the Regulation respecting the prescription of a medication by a pharmacist, except for the case referred to in item 6 or 12 of Schedule I to that regulation;

(o)  evaluation of the need for the prescription of a medication for a minor condition, according to the terms and conditions determined by the Regulation respecting certain professional activities that may be engaged in by a pharmacist;

The services referred to in subparagraphs (a) and (b) of the first paragraph must relate to a medication on the list of medications drawn up by the Minister under section 60 of the Act respecting prescription drug insurance (chapter A-29.01).

The services referred to in subparagraphs (c) and (e) of the first paragraph must relate to at least one medication on the list of medications drawn up by the Minister under section 60 of the Act respecting prescription drug insurance.

R.R.Q., 1981, c. A-29, r. 1, s. 60; O.C. 1770-84, s. 1; O.C. 505-2015, s. 1; S.Q. 2020, c. 4, s. 12.

2015-06-20

60. The pharmaceutical services referred to below must be deemed insured services for the purposes of the third and fourth paragraphs of section 3 of the Act:

(a)  filling and renewal of a prescription;

(b)  refusal to fill a prescription or to renew it;

(c)  pharmaceutical opinion (opinion with reasons of a pharmacist on the pharmaco-therapeutic history of an insured person prepared under his authority, or on the therapeutic value of on or all of the treatment ordered by prescription, given in writing to the prescriber);

(d)  transmission of a medication profile;

(e)  on-call service;

(f)  extension of a physician’s prescription, so that the treatment prescribed by the physician to a patient shall not be interrupted, according to the terms and conditions referred to in subparagraph (6) of the second paragraph of section 17 of the Pharmacy Act (chapter P-10) as well as in the Regulation respecting the extension or adjustment of a physician’s prescription by a pharmacist and the substitution of a medication prescribed (chapter P-10, r. 19.1);

(g)  adjustment of a physician’s prescription, by modifying the dosage form, dose, quantity or dosage regimen of a prescribed medication, according to the terms and conditions determined by the Regulation respecting the extension or adjustment of a physician’s prescription by a pharmacist and the substitution of a medication prescribed;

(h)  replacement of a prescribed medication, where it is completely out of stock in Québec, with another medication of the same therapeutic sub-class, according to the terms and conditions determined by the Regulation respecting the extension or adjustment of a physician’s prescription by a pharmacist and the substitution of a medication prescribed;

(i)  administration of a medication orally, topically, subcutaneously, intradermally or intramuscularly, or by inhalation, in order to establish its appropriate usage, according to the terms and conditions determined by the Regulation respecting the administration of medication by pharmacists (chapter P-10, r. 3.1);

(j)  prescription of laboratory analyses for the purpose of the monitoring of a medicational therapy by a pharmacist practising in a community pharmacy, according to the terms and conditions determined by the Regulation respecting certain professional activities that may be engaged in by a pharmacist (chapter M-9, r. 12.2);

(k)  prescription of a medication when no diagnosis is required, in the cases and according to the terms and conditions determined by the Regulation respecting the prescription of a medication by a pharmacist (chapter P-10, r. 18.2), except for the case referred to in item 6 of Schedule I to that regulation;

(l)  prescription of a medication for a minor condition, according to the terms and conditions determined by the Regulation respecting certain professional activities that may be engaged in by a pharmacist;

(m)  taking charge of the adjustment of a dose of a medication to attain a therapeutic target, according to the terms and conditions determined by the Regulation respecting the extension or adjustment of a physician’s prescription by a pharmacist and the substitution of a medication prescribed. The cost of tests performed in a pharmacy are not included in the pharmacist’s remuneration for this service;

(n)  evaluation of the need for the prescription of a medication when no diagnosis is required, in the cases and according to the terms and conditions determined by the Regulation respecting the prescription of a medication by a pharmacist, except for the case referred to in item 6 of Schedule I to that regulation;

(o)  evaluation of the need for the prescription of a medication for a minor condition, according to the terms and conditions determined by the Regulation respecting certain professional activities that may be engaged in by a pharmacist;

The services referred to in subparagraphs (a) and (b) of the first paragraph must relate to a medication on the list of medications drawn up by the Minister under section 60 of the Act respecting prescription drug insurance (chapter A-29.01).

The services referred to in subparagraphs (c) and (e) of the first paragraph must relate to at least one medication on the list of medications drawn up by the Minister under section 60 of the Act respecting prescription drug insurance.

R.R.Q., 1981, c. A-29, r. 1, s. 60; O.C. 1770-84, s. 1; O.C. 505-2015, s. 1.

2012-09-01

60. The pharmaceutical services referred to below must be deemed insured services for the purposes of the third and fourth paragraphs of section 3 of the Act:

(a)  filling and renewal of a prescription;

(b)  refusal to fill a prescription or to renew it;

(c)  pharmaceutical opinion (opinion with reasons of a pharmacist on the pharmaco-therapeutic history of an insured person prepared under his authority, or on the therapeutic value of on or all of the treatment ordered by prescription, given in writing to the prescriber).

R.R.Q., 1981, c. A-29, r. 1, s. 60; O.C. 1770-84, s. 1.